In response to high demand and to help patients whose health insurance doesn't cover the new GLP-1 weight loss drugs, the drugmaker is now offering Zepbound in smaller vials for $399 for a 4-week supply on its LillyDirect website.
The Treat and Reduce Obesity Act provides coverage for patients who had an insurance plan that covered the new weight loss drugs, like Wegovy and Ozempic, before they entered Medicare.
While shortages of the popular weight loss drugs persist, Hims & Hers, a San Francisco-based telehealth company, will offer access to a compounded form of the GLP-1 weight-loss drugs, starting at $199 a month.